Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Revenues $ 121,464,158 $ 50,895,151
Cost of revenues 55,201,078 19,570,257
Gross profit 66,263,080 31,324,894
Operating expenses:    
Personnel 8,351,397 5,501,756
Marketing and promotion 1,625,111 410,626
General and administrative 27,560,665 9,899,367
Bad debts 1,862,417 982,488
Total operating expenses 39,399,590 16,794,237
Operating income 26,863,490 14,530,657
Non-operating income (expenses):    
Interest expense (2,355,904) (9,810,475)
Interest income 108,219 156,345
Loss on obligations settled with equity (2,546) (44,678)
Equity in earnings of investments 98,813
Change in fair value of investments (1,106,593) (349,638)
Other 309,212 (84,708)
Total non-operating expenses, net (3,047,612) (10,034,341)
Income before income taxes 23,815,878 4,496,316
Provision for income taxes 16,192,327 2,067,049
Net income 7,623,551 2,429,267
Net income attributable to noncontrolling interests 399,030 285,278
Net income attributable to MariMed Inc. $ 7,224,521 $ 2,143,989
Net income per share    
Basic $ 0.02 $ 0.01
Diluted $ 0.02 $ 0.01
Weighted average common shares outstanding    
Basic 326,466,794 266,980,197
Diluted 372,396,731 324,160,525